Headquartered in Massechuset, Palomar Medical has declared that the US Patent and Trademark Office has confirmed the validity of 56 claims in the re-examination of US Patent No.
Headquartered in Yew York, OSI Pharmaceuticals has announced that the FDA has accepted for filing and review the supplemental New Drug Application (sNDA) for the use of Tarceva
New Jersey based PTC has announced the receipt of two government grants to support clinical development programs in rare disorders. The US Department of Defense Neurofibromatosis Research Program
Israel based Pluristem has announced that the Paul Ehrlich Institute (PEI), the German competent authority in the EU, has approved the Clinical Trial Application (CTA). EU has granted
The Society of Chemical Manufacturers and Affiliates (SOCMA) has announced the approval of five new companies for membership. The announcement was made on June 2 meeting of the
Genzyme has announced that the European Commission has approved Renvela (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease (CKD). Renvela is a
New Jersey based Orphan and Ikaria, have announced that the FDA has accepted the final section of the New Drug Application (NDA) filing seeking marketing approval for Lucassin
Misonix has announced today that it has purchased three patents associated with High Intensity Focused Ultrasound (HIFU) technology from ProRhythm. The patents relate to HIFU transducer arrays method
Headquartered in California, Jazz Pharmaceuticals has declared that its pain drug JZP-6 has shown clinically significant improvement in pain and core symptoms, associated with fibromyalgia. The result was
Protein Sciences (PSC) has started manufacturing vaccine against the H1N1(Swine flu) virus. The company has estimated to produce 100,000 doses this week, and will continue with the same
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.